"Younger women generally have a higher risk of recurrence than older postmenopausal women, but most studies on anti-hormonal therapy have mainly included postmenopausal women. We therefore wanted to compare the long-term benefit from the treatment in both groups," says Linda Lindstrom, associate professor and research group leader at the Department of Oncology-Pathology, Karolinska Institutet, who led the study.
from Science News - Times of India https://ift.tt/Ce4S9Rj
via
from Science News - Times of India https://ift.tt/Ce4S9Rj
via
Comments
Post a Comment